← FDA Drug Approvals (Drugs@FDA)
OSELTAMIVIR PHOSPHATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2023-10-03
Drug application
- FDA Application #
ANDA217467- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OSELTAMIVIR PHOSPHATE
- Generic name
- OSELTAMIVIR PHOSPHATE
- Active ingredients
- OSELTAMIVIR PHOSPHATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- INVAGEN PHARMS
- Manufacturer
- Exelan Pharmaceuticals, Inc.
- First approval
- 2023-10-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown